These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28531260)

  • 1. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.
    AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord
    Clin Infect Dis; 2017 Oct; 65(8):1316-1326. PubMed ID: 28531260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study.
    Rohner E; Valeri F; Maskew M; Prozesky H; Rabie H; Garone D; Dickinson D; Chimbetete C; Lumano-Mulenga P; Sikazwe I; Wyss N; Clough-Gorr KM; Egger M; Chi BH; Bohlius J
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):547-54. PubMed ID: 25393941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
    Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
    Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    ; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
    Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
    Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
    Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America.
    Castilho JL; Kim A; Jenkins CA; Grinsztejn B; Gotuzzo E; Fink V; Padgett D; Belaunzaran-Zamudio PF; Crabtree-Ramírez B; Escuder MM; Souza RA; Tenore SB; Pimentel SR; Ikeda MLR; de Alencastro PR; Tupinanbas U; Brites C; Luz E; Netto J; Cortes CP; Grangeiro A; Shepherd BE; McGowan CC;
    J Int AIDS Soc; 2021 Jan; 24(1):e25658. PubMed ID: 33405281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi sarcoma-associated herpesvirus, HIV-1 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout.
    Motlhale M; Muchengeti M; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Bender N; Mathew CG; Newton R; Waterboer T; Singh E; Sitas F
    Int J Cancer; 2023 May; 152(10):2081-2089. PubMed ID: 36727526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
    Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
    J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
    Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
    Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
    Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
    PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin lymphoma risk in adults living with HIV across five continents.
    AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord
    AIDS; 2018 Nov; 32(18):2777-2786. PubMed ID: 30234606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study.
    Akanbi MO; Bilaver LA; Achenbach C; Hirschhorn LR; Rivera AS; Adekolujo OS; Adekola KUA; Silas OA; Agaba PA; Agbaji O; Shehu NY; Sagay SA; Hou L; Murphy RL
    BMC Cancer; 2023 Sep; 23(1):890. PubMed ID: 37735371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
    Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
    BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study.
    Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
    Cancer Epidemiol; 2022 Jun; 78():102158. PubMed ID: 35421713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.